NovaBay Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
29 Contracts & Agreements
- Form of Letter Agreement (Filed With SEC on December 21, 2023)
- Description of Securities (Filed With SEC on March 31, 2023)
- Form of Leak-Out Agreement (Filed With SEC on September 13, 2022)
- Form of 2021 Reprice Letter Agreement (Filed With SEC on September 13, 2022)
- Form of 2020 Reprice Letter Agreement (Filed With SEC on September 13, 2022)
- Director and Officer Indemnity Agreement (Filed With SEC on March 29, 2022)
- Description of Securities (Filed With SEC on March 29, 2022)
- Side Letter with Dr. Audrey Kunin, dated November 5, 2021 (Filed With SEC on November 12, 2021)
- At the Market Offering Agreement, dated May 14, 2021 (Filed With SEC on May 14, 2021)
- Description of Securities (Filed With SEC on March 25, 2021)
- Indemnity Agreement (Form of Indemnity Agreement between the Company and its Directors and Officers) (Filed With SEC on August 6, 2020)
- Form of Reprice Agreement with Ladenburg (Filed With SEC on July 21, 2020)
- Form of Exercise Agreement with Holders of Foreign Warrants (Filed With SEC on July 21, 2020)
- Form of Exercise Agreement with Holders of Domestic Warrants (Filed With SEC on July 21, 2020)
- At the Market Offering Agreement, dated April 27, 2020 (Filed With SEC on April 27, 2020)
- Certificate of Designation (Filed With SEC on August 13, 2019)
- Letter Agreement, dated March 29, 2019, by and between the Company and Triton Funds LLC (Filed With SEC on April 1, 2019)
- AGREEMENT (Filed With SEC on March 26, 2015)
- SEVENTH AMENDMENT (Filed With SEC on August 9, 2012)
- CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 27, 2012)
- CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 10, 2011)
- CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 10, 2011)
- INDEMNITY AGREEMENT (Filed With SEC on August 12, 2010)
- EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on March 30, 2010)
- CONFIDENTIAL TREATMENT REQUESTED BY NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on March 30, 2010)
- Placement Agent Agreement, dated August 21, 2009, by and between NovaBay Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on August 21, 2009)
- NOVABAY PHARMACEUTICALS, INC. (Filed With SEC on August 14, 2008)
- AMENDMENT NUMBER 1 (the Amendment) (Filed With SEC on March 14, 2008)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on August 10, 2007)
